Dominik Ellenrieder is a businessperson who founded Kuros Biosurgery Holding AG and Kuros Therapeutics AG and who has been at the helm of 5 different companies. Mr. Ellenrieder occupies the position of Chairman for Sentec AG, Chairman of Qgel SA and Chairman for Senspec GmbH.
He is also on the board of Medartis Holding AG, Nexmed Holding AG and Le Grand Hotel Chandolin SA and Operating Partner at Endeavour Vision SA.
In the past Dominik Ellenrieder occupied the position of Chairman at Kuros Therapeutics AG, Chairman of Symetis SA, Director at Kuros Biosurgery Holding AG, Officer at Stratec Medical AGs and Head-International Sales at Sulzer Medica.
He received an undergraduate degree from the University of Basel and an MBA from Boston University.